The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment
- PMID: 3669156
- DOI: 10.1016/s0022-5347(17)43526-9
The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment
Abstract
The participation of oxalate in nephrolithiasis was evaluated in 202 stone patients. The activity product and formation product ratios of calcium oxalate were substantially altered in the stone population. Treatment with thiazide derivatives and/or allopurinol was able to decrease urine oxalate and normalize the activity product and formation product ratios. Stone activity decreased in the stone population after treatment. Our data suggest that oxalate may have a critical role in nephrolithiasis activity.
Similar articles
-
Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.Metabolism. 1977 Feb;26(2):201-5. doi: 10.1016/0026-0495(77)90056-7. Metabolism. 1977. PMID: 834153
-
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.Scand J Urol Nephrol Suppl. 1980;53:265-71. Scand J Urol Nephrol Suppl. 1980. PMID: 6938003
-
Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.Trans Assoc Am Physicians. 1983;96:294-305. Trans Assoc Am Physicians. 1983. PMID: 6679957
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Medical therapy, calcium oxalate urolithiasis.Urol Clin North Am. 1997 Feb;24(1):117-33. doi: 10.1016/s0094-0143(05)70358-x. Urol Clin North Am. 1997. PMID: 9048856 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources